vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and VEEVA SYSTEMS INC (VEEV). Click either name above to swap in a different company.

VEEVA SYSTEMS INC is the larger business by last-quarter revenue ($811.2M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). VEEVA SYSTEMS INC runs the higher net margin — 29.1% vs 6.8%, a 22.3% gap on every dollar of revenue. On growth, VEEVA SYSTEMS INC posted the faster year-over-year revenue change (16.0% vs -1.7%). Over the past eight quarters, VEEVA SYSTEMS INC's revenue compounded faster (13.4% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud software, data, and business consulting for the life sciences industry. Its software is used to manage data, track regulatory registrations, and oversee supply chains. The company is a public benefit corporation.

MD vs VEEV — Head-to-Head

Bigger by revenue
VEEV
VEEV
1.6× larger
VEEV
$811.2M
$493.8M
MD
Growing faster (revenue YoY)
VEEV
VEEV
+17.7% gap
VEEV
16.0%
-1.7%
MD
Higher net margin
VEEV
VEEV
22.3% more per $
VEEV
29.1%
6.8%
MD
Faster 2-yr revenue CAGR
VEEV
VEEV
Annualised
VEEV
13.4%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MD
MD
VEEV
VEEV
Revenue
$493.8M
$811.2M
Net Profit
$33.7M
$236.2M
Gross Margin
75.4%
Operating Margin
9.9%
29.7%
Net Margin
6.8%
29.1%
Revenue YoY
-1.7%
16.0%
Net Profit YoY
10.5%
27.1%
EPS (diluted)
$0.40
$1.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
VEEV
VEEV
Q4 25
$493.8M
$811.2M
Q3 25
$492.9M
$789.1M
Q2 25
$468.8M
$759.0M
Q1 25
$458.4M
$720.9M
Q4 24
$502.4M
$699.2M
Q3 24
$511.2M
$676.2M
Q2 24
$504.3M
$650.3M
Q1 24
$495.1M
$630.6M
Net Profit
MD
MD
VEEV
VEEV
Q4 25
$33.7M
$236.2M
Q3 25
$71.7M
$200.3M
Q2 25
$39.3M
$228.2M
Q1 25
$20.7M
$195.6M
Q4 24
$30.5M
$185.8M
Q3 24
$19.4M
$171.0M
Q2 24
$-153.0M
$161.7M
Q1 24
$4.0M
$147.4M
Gross Margin
MD
MD
VEEV
VEEV
Q4 25
75.4%
Q3 25
75.3%
Q2 25
77.1%
Q1 25
74.9%
Q4 24
75.1%
Q3 24
74.8%
Q2 24
73.3%
Q1 24
72.4%
Operating Margin
MD
MD
VEEV
VEEV
Q4 25
9.9%
29.7%
Q3 25
13.8%
24.8%
Q2 25
12.8%
30.8%
Q1 25
7.0%
26.1%
Q4 24
7.8%
25.9%
Q3 24
6.6%
24.6%
Q2 24
-31.3%
23.9%
Q1 24
3.2%
21.4%
Net Margin
MD
MD
VEEV
VEEV
Q4 25
6.8%
29.1%
Q3 25
14.5%
25.4%
Q2 25
8.4%
30.1%
Q1 25
4.5%
27.1%
Q4 24
6.1%
26.6%
Q3 24
3.8%
25.3%
Q2 24
-30.3%
24.9%
Q1 24
0.8%
23.4%
EPS (diluted)
MD
MD
VEEV
VEEV
Q4 25
$0.40
$1.40
Q3 25
$0.84
$1.19
Q2 25
$0.46
$1.37
Q1 25
$0.24
$1.17
Q4 24
$0.37
$1.13
Q3 24
$0.23
$1.04
Q2 24
$-1.84
$0.98
Q1 24
$0.05
$0.90

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
VEEV
VEEV
Cash + ST InvestmentsLiquidity on hand
$375.2M
$1.7B
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
$7.0B
Total Assets
$2.2B
$8.1B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
VEEV
VEEV
Q4 25
$375.2M
$1.7B
Q3 25
$340.1M
$1.9B
Q2 25
$224.7M
$2.0B
Q1 25
$99.0M
$1.1B
Q4 24
$229.9M
$1.0B
Q3 24
$103.8M
$1.2B
Q2 24
$19.4M
$1.2B
Q1 24
$8.0M
$703.5M
Total Debt
MD
MD
VEEV
VEEV
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
VEEV
VEEV
Q4 25
$865.9M
$7.0B
Q3 25
$890.7M
$6.6B
Q2 25
$833.8M
$6.2B
Q1 25
$789.2M
$5.8B
Q4 24
$764.9M
$5.5B
Q3 24
$732.5M
$5.2B
Q2 24
$706.5M
$4.9B
Q1 24
$856.2M
$4.6B
Total Assets
MD
MD
VEEV
VEEV
Q4 25
$2.2B
$8.1B
Q3 25
$2.2B
$8.0B
Q2 25
$2.1B
$7.8B
Q1 25
$2.0B
$7.3B
Q4 24
$2.2B
$6.5B
Q3 24
$2.1B
$6.3B
Q2 24
$2.0B
$6.2B
Q1 24
$2.2B
$5.9B
Debt / Equity
MD
MD
VEEV
VEEV
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
VEEV
VEEV
Operating Cash FlowLast quarter
$114.1M
$192.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
0.82×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
VEEV
VEEV
Q4 25
$114.1M
$192.8M
Q3 25
$137.3M
$238.4M
Q2 25
$137.2M
$877.2M
Q1 25
$-117.5M
$69.5M
Q4 24
$133.0M
$164.1M
Q3 24
$91.8M
$92.9M
Q2 24
$107.0M
$763.5M
Q1 24
$-125.2M
$57.8M
Cash Conversion
MD
MD
VEEV
VEEV
Q4 25
3.39×
0.82×
Q3 25
1.91×
1.19×
Q2 25
3.49×
3.84×
Q1 25
-5.66×
0.36×
Q4 24
4.36×
0.88×
Q3 24
4.72×
0.54×
Q2 24
4.72×
Q1 24
-31.03×
0.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

VEEV
VEEV

Subscription Services Veeva Research And Development$364.8M45%
Subscription Services Veeva Commercial Cloud$317.6M39%
Professional Services Veeva Research And Development$81.3M10%
Professional Services Veeva Commercial Cloud$47.5M6%

Related Comparisons